Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Parkinsonism is a term for a group of neurological conditions that cause movement problems including tremors, slowed movement and stiffness, with Parkinson's disease being one of the better knowns causes.

24 Mar 2022

Computer algorithm predicts coronary artery disease-related events based on voice recordings

An artificial intelligence (AI)-based computer algorithm accurately predicted a person's likelihood of suffering heart problems related to clogged arteries based on voice recordings alone, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

24 Mar 2022

Blood biomarker may uniquely aid prediction of dementia in Mexican Americans

Blood levels of a biomarker called glial fibrillary acidic protein (GFAP) may uniquely aid prediction of dementia in Mexican Americans, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and collaborating institutions reported March 24.

24 Mar 2022

Niacin limits Alzheimer's disease progression in animal model

Indiana University School of Medicine researchers found that niacin limits Alzheimer's disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic approaches to the disease.

23 Mar 2022

UI neuroscientists identify fundamental biochemical mechanism underlying memory storage

A University of Iowa neuroscience research team has identified a fundamental biochemical mechanism underlying memory storage and has linked this mechanism to cognitive deficits in mouse models of Alzheimer's Disease and Related Dementias.

23 Mar 2022

Researchers find two gene variants linked to accelerated aging in childhood cancer survivors

Scientists from St. Jude Children's Research Hospital have identified variants in two genes that are associated with accelerated aging in childhood cancer survivors. Their research looked at the difference between their biological age and chronological age.

23 Mar 2022

Ignoring cholesterol and glucose levels at age 35 may impact the chances of getting Alzheimer's later

Living your best life at 35, ignoring cholesterol and glucose levels, may impact your chances of getting Alzheimer's disease (AD) later in life.

23 Mar 2022

Virtual reality test could offer a promising way of effectively assessing functional cognition in adults

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London suggests that a virtual reality test in which participants "go to the shops" could offer a potentially promising way of effectively assessing functional cognition, the thinking and processing skills needed to accomplish complex everyday activities

23 Mar 2022

UTA researcher receives NIH grant to map the brain for early detection of Alzheimer's disease

A University of Texas at Arlington computer science and engineering assistant professor has received a National Institutes of Health grant to map the brain in an effort to detect Alzheimer's disease earlier.

22 Mar 2022

AAN issues practice advisory for preventing second stroke in people with intracranial atherosclerosis

The use of medications and exercise is more beneficial in preventing a second stroke in people with intracranial atherosclerosis than placing a stent in the blood vessel, according to a new practice advisory issued by the American Academy of Neurology.

22 Mar 2022

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

A research collaboration between scientists at LSU Health New Orleans and the Karolinska Institutet in Sweden has found that applying specialized pro-resolving lipid mediators intranasally arrested memory loss and brain degeneration in an experimental model of Alzheimer's Disease (AD).

21 Mar 2022

TTUHSC secures $1.87 million grant to investigate the impact of vitamin A depletion on Alzheimer’s disease

Ongoing research suggests that an accumulation of toxic reactive oxygen species (ROS) in the area of the brain known as the hippocampal dentate gyrus may begin early on in patients with Alzheimer's disease.

21 Mar 2022

Study: Targeting astrocytes reduces tau-related brain damage and inflammation in mice

Alzheimer's disease is the most common and best known of the tauopathies, a set of neurodegenerative brain diseases caused by toxic tangles of the protein tau.

18 Mar 2022

A complete transcriptomic analysis of astrocytes in Alzheimer's disease

An international group of researchers led by the UAB analyzed the genes that are expressed in neurons and astrocytes based on data from 800 individuals and compared what happens in Alzheimer's patients and in people without diagnosed dementia.

18 Mar 2022

Excessive daytime napping among older people may foreshadow dementia

Daytime napping among older people is a normal part of aging – but it may also foreshadow Alzheimer's disease and other dementias.

18 Mar 2022

University of Kentucky begins world’s first clinical trial for LATE

The motivation driving the work of Pete Nelson, M.D., Ph.D., is personal. His grandmother, Sylvia Becker, died with Alzheimer's disease, and he says his mother then grew terrified of developing the disease.

17 Mar 2022

Lithium use linked to reduced risk of developing dementia

Researchers have identified a link suggesting that lithium could decrease the risk of developing dementia, which affects nearly one million people in the UK.

17 Mar 2022

People with elevated blood pressure upon standing more likely to have risk for cardiovascular events

Among young and middle-aged adults with high blood pressure, a substantial rise in blood pressure upon standing may identify those with a higher risk of serious cardiovascular events, such as heart attack and stroke, according to new research published today in the American Heart Association's peer-reviewed journal Hypertension.

17 Mar 2022

Elevated triglyceride levels may increase risk of second stroke, even while on statin therapy

Stroke can have many causes. An atherothrombotic stroke is caused by a clot that forms from plaques that build up within blood vessels in the brain.

16 Mar 2022

Neuropsychiatric symptoms develop predominantly due to Alzheimer’s pathology, not cognitive decline

Alzheimer's disease (AD) eventually leads to severe cognitive decline, but most affected individuals also develop distressing neuropsychiatric symptoms.

16 Mar 2022

Alzheimer's Disease News and Research

Further Reading

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Computer algorithm predicts coronary artery disease-related events based on voice recordings

Blood biomarker may uniquely aid prediction of dementia in Mexican Americans

Niacin limits Alzheimer's disease progression in animal model

UI neuroscientists identify fundamental biochemical mechanism underlying memory storage

Researchers find two gene variants linked to accelerated aging in childhood cancer survivors

Ignoring cholesterol and glucose levels at age 35 may impact the chances of getting Alzheimer's later

Virtual reality test could offer a promising way of effectively assessing functional cognition in adults

UTA researcher receives NIH grant to map the brain for early detection of Alzheimer's disease

AAN issues practice advisory for preventing second stroke in people with intracranial atherosclerosis

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

TTUHSC secures $1.87 million grant to investigate the impact of vitamin A depletion on Alzheimer’s disease

Study: Targeting astrocytes reduces tau-related brain damage and inflammation in mice

A complete transcriptomic analysis of astrocytes in Alzheimer's disease

Excessive daytime napping among older people may foreshadow dementia

University of Kentucky begins world’s first clinical trial for LATE

Lithium use linked to reduced risk of developing dementia

People with elevated blood pressure upon standing more likely to have risk for cardiovascular events

Elevated triglyceride levels may increase risk of second stroke, even while on statin therapy

Neuropsychiatric symptoms develop predominantly due to Alzheimer’s pathology, not cognitive decline

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News